In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Excerpts from recent editorials in the United States and abroad: ___ Jan. 26 The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, ...

Sanofi-Synthélabo is known for creating meningitis treatment, Menactra, diabetes treatment Lantus, colorectal cancer drug Eloxatin ... use the name Sanofi-Aventis. This merger helped the two ...

It became the first drug approved to claim it can significantly ... obesity is Saxenda (Victoza under a different dose and brand name), which Maziar Mike Doustdar says is making in-roads in ...

At present no reports on glulisine use in pregnancy are available. [53] Insulin Glargine. The first long-acting insulin analogue was approved for clinical use in patients with Type 1 and Type 2 ...

Adding lanreotide to everolimus significantly prolonged progression-free survival compared with everolimus alone in patients ...

Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...

section. Mounjaro is a brand-name medication. It contains the active ingredient tirzepatide. (An active ingredient is what makes a drug work.) A generic version of the drug isn’t currently ...

Patrick Mahomes and the Chiefs earned a first-round bye in the 2025 playoffs after finishing as the No. 1 seed in the AFC. Even though the team was off, the Kansas City quarterback was certainly busy.

Drug delivery describes the method and approach to delivering drugs or pharmaceuticals and other xenobiotics to their site of action within an organism, with the goal of achieving a therapeutic ...

Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. An ...